Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-06-22
1997-08-05
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 514 15, 514 16, 514 17, 530324, 530325, 530326, 530327, 530328, 530329, 530330, 530331, 530300, A61K 3800, C07K 500, C07K 700
Patent
active
056542720
ABSTRACT:
The invention relates to radiolabeled imaging of a mammalian body. The invention in particular provides for reagents labeled with technetium-99m for such imaging. The invention provides peptides which bind technetium-99m and which can be targeted to specific sites within a mammalian body.
REFERENCES:
patent: 4434151 (1984-02-01), Byrne et al.
patent: 4444690 (1984-04-01), Fritzberg
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4571430 (1986-02-01), Byrne et al.
patent: 4575556 (1986-03-01), Bryne et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4792525 (1988-12-01), Ruoslahti et al.
patent: 4857508 (1989-08-01), Adams et al.
patent: 4861869 (1989-08-01), Nicolotti et al.
patent: 4965392 (1990-10-01), Fritzberg et al.
Takeda et al., Chemical Pharmaceutical Bulletin, vol. 36 (7), pp. 2570-2575 (1988).
Rhodes, 1974, "Considerations in the Radiolabeling of Albumin", Sem. Nucl. Med. 4: 281-293.
Davidson et al., 1981, "A New Class of Oxotechnetium(5+) Chelate Complexes containing a TcON.sub.2 S.sub.2 Core", Inorg. Chem. 20: 1629-1632.
Fritzberg et al., 1982, "Synthesis and Biological Evaluation of Tc-99m N,N'-Bis(mercaptoacetyl)-2,3-diaminopropanoate: A Potential Replacement for [.sup.131 I]o-iodohippurate", J. Nucl. Med. 23: 592-598.
Fritzberg et al., 1982, "Clinical comparison of Tc-99m N,N'-bis(mercaptoacetamido)ethylenediamine and (.sup.131 I)ortho-iodohippurate for evaluation of renal tubular function: Concise Communication", J. Nucl. Med. 23:P17.
Khaw et al., 1982, "Technetium-99m Labeling of Antibodies to Cardiac Myosin Fab and to Human Fibrinogen", J. Nucl. Med. 23: 1011-1019.
Byrne and Tolman, 1983, "Technetium-99m Bifunctional Chelating Agent--Thiolactone for Coupling to Biomolecules, N.sub.2 S.sub.2 Ligand for Chelation to Technetium", J. Nucl. Med. 24:P126.
Bryson et al., 1988, "Neutral Technetium(V) Complexes with Amide-Thiol-Thioether Chelating Ligands", Inorg. Chem. 27:2154-2161.
Bryson et al., 1990, "Protecting Groups inb the Preparation of Thiolate Complexes of Technetium", Inorg. Chem. 29: 2948-2951.
Knight et al., 1990, "Thrombus Imaging with Tc-99m Synthetic peptides Reactive with Activated Platelets", J. Nucl. Med. 31: 757 #209.
Davenport Avis M.
Diatide, Inc.
LandOfFree
Technetium-99m labeled polypeptides for imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium-99m labeled polypeptides for imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium-99m labeled polypeptides for imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1074812